PDGFRB and oligodendroglioma: The effects of PTK787, a PDGFR and vascular‐endothelial growth factor receptor (VEGFR) inhibitor, have been tested in the aforementioned RCAS‐PDGF‐mediated oligodendroglioma model 72, 80.